Log in  First Connection?

DialysisArchives

Clinical characteristics and survival among HIV-infected people undergoing maintenance hemodialysis: a comparative study from Shanghai, China
Dialysis
 4 min.

 Published on 04/02/2026 |  Original article (Full-text)  | Le Xiaoqin et al. | BMC Infectious Diseases 2025; 26(1): 221

Since the first case of AIDS was reported in 1981, approximately 88.4 million people have become infected with HIV, resulting in an estimated 42.3 million deaths by 2023 [1]. The widespread adoption of highly active antiretroviral therapy (ART) has significantly improved overall survival and life expectancy...

Knowledge, perceptions, and willingness to undergo kidney transplantation among patients with kidney failure receiving hemodialysis in Southern Morocco
Dialysis
 6 min.

 Published on 28/01/2026 |  Original article (Full-text)  | Dakhama Yasmine et al. | BMC Nephrology 2025; 27(1): 65

Chronic kidney disease (CKD) is a major public health burden, with approximately 674 million people living with the disease, representing 9% of the global population. It is among the fastest-growing non communicable illnesses with increasing trends of morbidity and mortality. By 2050, it will be the...

Serum magnesium and risk of arteriovenous fistula thrombosis in hemodialysis: a retrospective cohort study
Dialysis
 6 min.

 Published on 21/01/2026 |  Original article (Full-text)  | Stepanova Natalia et al. | BMC Nephrology 2025; 27(1): 43

Arteriovenous fistula (AVF) thrombosis is a major cause of vascular access failure among patients undergoing maintenance hemodialysis (HD), leading to increased morbidity, frequent hospitalizations, and higher healthcare costs [1, 2]. Despite advances in surgical technique and access surveillance, the...

A narrative review of routine haematological and biochemical parameter monitoring in maintenance haemodialysis patients and comparison of clinical guidelines
Dialysis
 6 min.

 Published on 14/01/2026 |  Original article (Full-text)  | Luu Harry H. et al. | BMC Nephrology 2025; 27(1): 19

Haemodialysis (HD) is the most common kidney replacement therapy for people with kidney failure. Clinical goals for people with kidney failure focus on improving quality of life; and routine laboratory testing of haematological and biochemical parameters has become integrated into those receiving HD...